Results for tag: "Kernicterus Drug"

Kernicterus is a rare neurological disorder caused by an accumulation of bilirubin in the brain. It is most commonly seen in newborns, and is treated with drugs that target the central nervous system. These drugs are used to reduce the levels of bilirubin in the brain, and to prevent further damage to the brain. The Kernicterus drug market is composed of a variety of drugs, including anticonvulsants, anti-inflammatory agents, and other medications. These drugs are used to reduce the levels of bilirubin in the brain, and to prevent further damage to the brain. The Kernicterus drug market is highly specialized, and is composed of a few major players. Some of the companies in the market include Novartis, Pfizer, Merck, and Sanofi. These companies are focused on developing and marketing drugs to treat Kernicterus, and are committed to providing safe and effective treatments for this rare disorder. Show Less Read more